Magnesium Sulfate in Addition to Bupivacaine in Ultrasound-guided Transmuscular Quadratus Lumborum Block for Post-Operative Analgesia After Total Hip Arthroplasty
Recruiting
Phase 2
Phase 3
Interventional Study
Pain Score Reduction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 2/3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 70 (estimated)
- Sponsor
- Tanta University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this clinical trial is to evaluate the efficacy of adding magnesium sulfate to bupivacaine in ultrasound-guided transmuscular quadratus lumborum block for postoperative analgesia in adult patients underdoing hip arthroplasty. The main questions it aims to answer are:
* Does Magnesium sulphate lower Pain score (VAS) postoperatively.
* Does Magnesium sulphate lowerTotal opioid consumptio…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years.
* American Society of Anesthesiology (ASA) class I-III
* Undergoing hip arthroplasty .
Exclusion Criteria:
* Patient refusal.
* Body mass index (BMI) \> 40 Kg/m2.
* Allergy to local anesthetics or magnesium sulphate.
* coexisting coagulopathy.
* Local infecti…
Contacts